Intelligent Bronchial Isolation Systems

Publication ID: 24-11857406_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Bronchial Isolation Systems,” Published Technical Disclosure No. 24-11857406_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857406_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,406.

Summary of the Inventive Concept

The invention integrates patented flow control devices with advanced technologies like AI, IoT, blockchain, and nanomaterials to create a synergistic system for treating lung diseases, enhancing patient outcomes, and optimizing bronchial isolation procedures.

Background and Problem Solved

The original patent disclosed flow control devices for treating lung diseases, but it had limitations in terms of optimizing device settings, monitoring patient data, and ensuring secure data management. The new inventive concept addresses these limitations by combining the patented flow control devices with cutting-edge technologies to create a more powerful and effective system.

Detailed Description of the Inventive Concept

The system consists of a flow control device configured to transition between a closed configuration that blocks air flow in the inspiratory direction and an open configuration that permits air flow in an expiratory direction. Additionally, the system includes a machine learning module that analyzes patient data to predict optimal flow control settings, IoT sensors to monitor fluid flow dynamics, a blockchain-based data management system to securely store and share patient data, and a nanomaterial-based coating to enhance the valve's durability and resistance to corrosion. The system also utilizes AI-assisted image analysis to identify optimal implantation sites and simulates various procedure scenarios to predict outcomes and minimize risks.

Novelty and Inventive Step

The new claims introduce the integration of advanced technologies with the patented flow control devices, which is a novel and non-obvious combination that significantly enhances the system's functionality and effectiveness.

Alternative Embodiments and Variations

Other embodiments of the inventive concept could include using different machine learning algorithms, incorporating additional sensors or data sources, or developing new nanomaterial-based coatings. The system could also be adapted for use in other medical applications beyond lung disease treatment.

Potential Commercial Applications and Market

The intelligent bronchial isolation system has significant commercial potential in the medical device industry, particularly in the treatment of lung diseases such as COPD. The system's ability to optimize device settings, monitor patient data, and ensure secure data management makes it an attractive solution for healthcare providers and patients alike.

CPC Classifications

SectionClassGroup
A A61 A61F2/04
A A61 A61M16/209
A A61 A61F2002/043
A A61 A61M2205/04

Original Patent Information

Patent NumberUS 11,857,406
TitleHigh resistance implanted bronchial isolation devices and methods
Assignee(s)Pulmonx Corporation